Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Contrafect (CFRX)

Contrafect (CFRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 535
  • Shares Outstanding, K 10,705
  • Annual Sales, $ 0 K
  • Annual Income, $ -65,150 K
  • 60-Month Beta 0.29
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade CFRX with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -19.27
  • Most Recent Earnings $-0.50 on 11/14/23
  • Latest Earnings Date 11/13/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0430 +16.28%
on 11/13/23
0.2755 -81.85%
on 11/06/23
-0.2069 (-80.54%)
since 11/03/23
3-Month
0.0430 +16.28%
on 11/13/23
1.0400 -95.19%
on 09/07/23
-0.7277 (-93.57%)
since 09/05/23
52-Week
0.0430 +16.28%
on 11/13/23
13.0160 -99.62%
on 12/06/22
-11.3900 (-99.56%)
since 12/05/22

Most Recent Stories

More News
ContraFect: Q3 Earnings Snapshot

ContraFect: Q3 Earnings Snapshot

CFRX : 0.0500 (-27.95%)
ContraFect: Q2 Earnings Snapshot

ContraFect: Q2 Earnings Snapshot

CFRX : 0.0500 (-27.95%)
ContraFect: Q1 Earnings Snapshot

ContraFect: Q1 Earnings Snapshot

CFRX : 0.0500 (-27.95%)
ContraFect: Q4 Earnings Snapshot

ContraFect: Q4 Earnings Snapshot

CFRX : 0.0500 (-27.95%)
ContraFect Announces Independent DSMB Recommends Exebacase Phase 3 DISRUPT Study Be Stopped for Futility Following Interim Analysis

YONKERS, N.Y., July 13, 2022 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a biotechnology company focused on the discovery and development...

CFRX : 0.0500 (-27.95%)
Presentations at ASM Microbe Conference Demonstrate Potential of ContraFect’s Direct Lytic Agents (DLAs) to Address MRSA Infections

YONKERS, N.Y., June 14, 2022 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the...

CFRX : 0.0500 (-27.95%)
ContraFect to Present Data Demonstrating the Potential of Its Direct Lytic Agents (DLAs) to Combat MRSA at ASM Microbe 2022

YONKERS, N.Y., June 06, 2022 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the...

CFRX : 0.0500 (-27.95%)
ContraFect Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

YONKERS, N.Y., May 20, 2022 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX) (ContraFect), a late clinical-stage biotechnology company focused...

CFRX : 0.0500 (-27.95%)
ContraFect Reports First Quarter 2022 Financial Results and Provides Business Update

Phase 3 DISRUPT study achieves enrollment of MRSA patients necessary for DSMB to conduct interim futility analysis...

CFRX : 0.0500 (-27.95%)
Keynotes, Educational Panels and 88 Companies to Present at the Planet MicroCap Showcase on May 3-5, 2022 at Bally's Hotel & Casino in Las Vegas, NV

LOS ANGELES, CA / ACCESSWIRE / April 27, 2022 / SNN Network presents the Planet MicroCap Showcase taking place on May 3-5, 2022, where 88 MicroCap public and private companies will be presenting at Bally's...

CHL.AX : 1.805 (-1.37%)
DCM : 25.60 (-1.35%)
DDDX : 0.0184 (+3.37%)
AAT.VN : 0.025 (unch)
AATGF : 0.0398 (+109.47%)
ASTR.VN : 0.170 (unch)
AMI.VN : 0.135 (unch)
AUUD : 2.1300 (+12.11%)
AYRO : 1.2900 (-0.77%)
BNXA.VN : 0.660 (unch)
BNXAF : 0.4757 (-6.56%)
BICX : 1.4700 (-2.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.0757
2nd Resistance Point 0.0689
1st Resistance Point 0.0594
Last Price 0.0500
1st Support Level 0.0431
2nd Support Level 0.0363
3rd Support Level 0.0268

See More

52-Week High 13.0160
Fibonacci 61.8% 8.0603
Fibonacci 50% 6.5295
Fibonacci 38.2% 4.9987
Last Price 0.0500
52-Week Low 0.0430

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar